molecular-cancer.com Report : Visit Site


  • Server:Oscar Platform 20180...

    The main IP address: 96.45.82.109,Your server United States,Reston ISP:Tiggee LLC  TLD:com CountryCode:US

    The description :

    as an internationally recognized journal, molecular cancer is dedicated to the innovation of how basic cancer research drives advances in cancer prevention, diagnostics, and treatment. ranke...

    This report updates in 23-Oct-2018

Created Date:2001-12-27
Changed Date:2017-12-21

Technical data of the molecular-cancer.com


Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host molecular-cancer.com. Currently, hosted in United States and its service provider is Tiggee LLC .

Latitude: 38.938861846924
Longitude: -77.34619140625
Country: United States (US)
City: Reston
Region: Virginia
ISP: Tiggee LLC

the related websites

HTTP Header Analysis


HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-272 containing the details of what the browser wants and will accept back from the web server.

Content-Length:19176
X-Forwarded-Host:molecular-cancer.biomedcentral.com
Etag:"0ac0568b69bca488cb28f9473353e757"
X-Cache-Hits:0
X-Frame-Options:DENY
X-Served-By:cache-jfk8150-JFK
Expires:0
X-Sn-Servicetimems:133
Date:Mon, 22 Oct 2018 17:01:51 GMT
Age:0, 0
X-Xss-Protection:1; mode=block
X-Cache:MISS
X-Cdn-Origin:CF_live
Accept-Ranges:bytes, bytes
Strict-Transport-Security:max-age=31536000;includeSubDomains;preload
Content-Md5:CsBWi2m8pIjLKPlHM1PnVw==
Connection:keep-alive
Server:Oscar Platform 201802052158-272
X-B3-Sampled:0
Via:1.1 varnish
X-Content-Type-Options:nosniff
Content-Encoding:gzip
X-Timer:S1540227711.204796,VS0,VE238
Vary:Accept-Encoding,Accept,x-oscar-cache-mode,x-springer-property-json,X-Frame-Options
X-Vcap-Request-Id:2742ecae-6ab1-4d1b-4e7e-bbf684ef955e, de1e8efb-fae5-4727-783b-eb6896a17ee8
Cache-Control:private, must-revalidate
Content-Type:text/html; charset="UTF-8"

DNS

soa:ns10.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2009010153 43200 3600 1209600 180
ns:ns14.dnsmadeeasy.com.
ns13.dnsmadeeasy.com.
ns10.dnsmadeeasy.com.
ns12.dnsmadeeasy.com.
ns15.dnsmadeeasy.com.
ns11.dnsmadeeasy.com.
ipv4:IP:96.45.82.109
ASN:16552
OWNER:TIGGEE - Tiggee LLC, US
Country:US
IP:96.45.82.248
ASN:16552
OWNER:TIGGEE - Tiggee LLC, US
Country:US
IP:96.45.83.224
ASN:16552
OWNER:TIGGEE - Tiggee LLC, US
Country:US
IP:96.45.83.39
ASN:16552
OWNER:TIGGEE - Tiggee LLC, US
Country:US
mx:MX preference = 10, mail exchanger = mx2-class2-grp1.springernature.com.
MX preference = 10, mail exchanger = mx1-class2-grp1.springernature.com.

HtmlToText

skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search molecular cancer menu home about articles submission guidelines search submit a manuscript call for papers: thematic series 2019 series title: microvesicles and tumor microenvironment in cancer development and resistance to therapies the tumor microenvironment (tme) has an effect on tumor development, growth, and resistance to therapy. continuous interactions and exchanges between tumor cells and the tme are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis. molecular cancer is delighted to present this series that aims to highlight significant findings and advances in our understanding of the role of the tme in cancer biology. some areas of interest include, but are not limited to, hypoxia, microvesicles/exosomes, chemokines, carcinoma associated fibroblasts, tumor-infiltrating lymphocytes, and tumor associated macrophages and the clinical applications/drug development to target the tme and tumor cells. we welcome submission of research articles, letters to the editor, and original reviews. the submission deadline is december 20 th , 2018. to submit your manuscript, please use our online submission system available here . when finalizing the submission, use the drop-down menu in the 'additional information' tab to specify that you are submitting to this special issue. new associate editors recruitment molecular cancer invites you to join our team of academic editors in assessing manuscripts. for consideration, please send your cv to [email protected]. thematic series published in 2018 oncogenic signaling of tyrosine kinase in cancer: challenges and therapeutic opportunities-- the latest reviews in molecular cancer articles recent most accessed content type: research | 22 october 2018 targeting histone methyltransferase g9a inhibits growth and wnt signaling pathway by epigenetically regulating hp1α and apc2 gene expression in non-small cell lung cancer authors: keqiang zhang, jinhui wang, lu yang, yate-ching yuan, tommy r. tong, jun wu, xinwei yun, melissa bonner, rajendra pangeni, zheng liu, tiger yuchi, jae y. kim and dan j. raz content type: letter to the editor | 20 october 2018 targeting metabolic flexibility via angiopoietin-like 4 protein sensitizes metastatic cancer cells to chemotherapy drugs authors: maegan miang kee lim, jonathan wei kiat wee, jen chi soong, damien chua, wei ren tan, marco lizwan, yinliang li, ziqiang teo, wilson wen bin goh, pengcheng zhu and nguan soon tan content type: research | 18 october 2018 circular rna yap1 inhibits the proliferation and invasion of gastric cancer cells by regulating the mir-367-5p/p27 kip1 axis authors: hui liu, yuan liu, zhaolian bian, jing zhang, rui zhang, xiaoyu chen, yanxia huang, yang wang and jinshui zhu content type: letter to the editor | 17 october 2018 pan-cancer analysis of tumor metabolic landscape associated with genomic alterations authors: hongyoon choi and kwon joong na content type: research | 15 october 2018 regulation of sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer authors: courtney m schaal, namrata bora-singhal, durairaj mohan kumar and srikumar p chellappan most recent articles rss view all articles content type: research | 28 september 2014 down regulation of thrombospondin2 predicts poor prognosis in patients with gastric cancer authors: ruochuan sun, jifeng wu, yuanyuan chen, mingdian lu, shangxin zhang, daru lu and yongxiang li content type: research | 9 october 2014 histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer authors: donatella del bufalo, marianna desideri, teresa de luca, marta di martile, chiara gabellini, valentina monica, simone busso, adriana eramo, ruggero de maria, michele milella and daniela trisciuoglio content type: review | 2 august 2013 the complexity of nf-κb signaling in inflammation and cancer authors: bastian hoesel and johannes a schmid content type: research | 22 july 2010 cannabinoids reduce erbb2-driven breast cancer progression through akt inhibition authors: maría m caffarel, clara andradas, emilia mira, eduardo pérez-gómez, camilla cerutti, gema moreno-bueno, juana m flores, isabel garcía-real, josé palacios, santos mañes, manuel guzmán and cristina sánchez content type: review | 29 may 2014 muc16 (ca125): tumor biomarker to cancer therapy, a work in progress authors: mildred felder, arvinder kapur, jesus gonzalez-bosquet, sachi horibata, joseph heintz, ralph albrecht, lucas fass, justanjyot kaur, kevin hu, hadi shojaei, rebecca j whelan and manish s patankar most accessed articles rss view all articles editor-in-chief christophe nicot, kansas university medical center, usa aims and scope molecular cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science. read more impact factor molecular cancer has an impact factor of 7.776 and is ranked in the top 10% of both its jcr categories. it is currently ranked at 27 out of 292 (q1) in the biochemistry and molecular biology category and 22 out of 222 (q1) in the oncology category of journal citation reports. advertisement submit a manuscript editorial board sign up for article alerts and news from this journal 2017 journal metrics speed 64 days from submission to first decision 13 days from acceptance to publication citation impact 7.776 - 2-year impact factor 6.335 - 5-year impact factor 1.682 - source normalized impact per paper (snip) 2.778 - scimago journal rank (sjr) usage 1,007,008 downloads social media impact 369 mentions more about our metrics advertisement molecular cancer issn: 1476-4598 contact us submission enquiries: access here and click contact us general enquiries: [email protected] explore journals get published about bmc read more on our blogs receive bmc newsletters manage article alerts language editing for authors scientific editing for authors policies accessibility press center contact us leave feedback careers follow bmc bmc twitter page bmc facebook page bmc google plus page bmc weibo page by using this website, you agree to our terms and conditions , privacy statement and cookies policy. manage the cookies we use in the preference centre. © 2018 biomed central ltd unless otherwise stated. part of springer nature .

URL analysis for molecular-cancer.com


https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0895-9
https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-13-129
https://molecular-cancer.biomedcentral.com/articles/most-accessed/rss.xml
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0902-1
https://molecular-cancer.biomedcentral.com/submission-guidelines
https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-12-86
https://molecular-cancer.biomedcentral.com/articles
https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-13-230
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0901-2
https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0904-z
https://molecular-cancer.biomedcentral.com/about
https://molecular-cancer.biomedcentral.com/articles/most-recent/rss.xml
http://molecular-cancer.biomedcentral.com/about
https://molecular-cancer.biomedcentral.com/#tab-1
https://molecular-cancer.biomedcentral.com/#main-content

Whois Information


Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: MOLECULAR-CANCER.COM
Registry Domain ID: 81629963_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.eurodns.com
Registrar URL: http://www.EuroDNS.com
Updated Date: 2017-12-21T04:28:04Z
Creation Date: 2001-12-27T09:59:57Z
Registry Expiry Date: 2018-12-27T09:59:57Z
Registrar: EuroDNS S.A
Registrar IANA ID: 1052
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +352.27220150
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS10.DNSMADEEASY.COM
Name Server: NS11.DNSMADEEASY.COM
Name Server: NS12.DNSMADEEASY.COM
Name Server: NS13.DNSMADEEASY.COM
Name Server: NS14.DNSMADEEASY.COM
Name Server: NS15.DNSMADEEASY.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-22T16:53:44Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR EuroDNS S.A

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =molecular-cancer.com

  PORT 43

  TYPE domain

DOMAIN

  NAME molecular-cancer.com

  CHANGED 2017-12-21

  CREATED 2001-12-27

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  NS10.DNSMADEEASY.COM 208.94.148.4

  NS11.DNSMADEEASY.COM 208.80.124.4

  NS12.DNSMADEEASY.COM 208.80.126.4

  NS13.DNSMADEEASY.COM 208.80.125.4

  NS14.DNSMADEEASY.COM 208.80.127.4

  NS15.DNSMADEEASY.COM 208.94.149.4

  REGISTERED yes

Go to top

Mistakes


The following list shows you to spelling mistakes possible of the internet users for the website searched .

  • www.umolecular-cancer.com
  • www.7molecular-cancer.com
  • www.hmolecular-cancer.com
  • www.kmolecular-cancer.com
  • www.jmolecular-cancer.com
  • www.imolecular-cancer.com
  • www.8molecular-cancer.com
  • www.ymolecular-cancer.com
  • www.molecular-cancerebc.com
  • www.molecular-cancerebc.com
  • www.molecular-cancer3bc.com
  • www.molecular-cancerwbc.com
  • www.molecular-cancersbc.com
  • www.molecular-cancer#bc.com
  • www.molecular-cancerdbc.com
  • www.molecular-cancerfbc.com
  • www.molecular-cancer&bc.com
  • www.molecular-cancerrbc.com
  • www.urlw4ebc.com
  • www.molecular-cancer4bc.com
  • www.molecular-cancerc.com
  • www.molecular-cancerbc.com
  • www.molecular-cancervc.com
  • www.molecular-cancervbc.com
  • www.molecular-cancervc.com
  • www.molecular-cancer c.com
  • www.molecular-cancer bc.com
  • www.molecular-cancer c.com
  • www.molecular-cancergc.com
  • www.molecular-cancergbc.com
  • www.molecular-cancergc.com
  • www.molecular-cancerjc.com
  • www.molecular-cancerjbc.com
  • www.molecular-cancerjc.com
  • www.molecular-cancernc.com
  • www.molecular-cancernbc.com
  • www.molecular-cancernc.com
  • www.molecular-cancerhc.com
  • www.molecular-cancerhbc.com
  • www.molecular-cancerhc.com
  • www.molecular-cancer.com
  • www.molecular-cancerc.com
  • www.molecular-cancerx.com
  • www.molecular-cancerxc.com
  • www.molecular-cancerx.com
  • www.molecular-cancerf.com
  • www.molecular-cancerfc.com
  • www.molecular-cancerf.com
  • www.molecular-cancerv.com
  • www.molecular-cancervc.com
  • www.molecular-cancerv.com
  • www.molecular-cancerd.com
  • www.molecular-cancerdc.com
  • www.molecular-cancerd.com
  • www.molecular-cancercb.com
  • www.molecular-cancercom
  • www.molecular-cancer..com
  • www.molecular-cancer/com
  • www.molecular-cancer/.com
  • www.molecular-cancer./com
  • www.molecular-cancerncom
  • www.molecular-cancern.com
  • www.molecular-cancer.ncom
  • www.molecular-cancer;com
  • www.molecular-cancer;.com
  • www.molecular-cancer.;com
  • www.molecular-cancerlcom
  • www.molecular-cancerl.com
  • www.molecular-cancer.lcom
  • www.molecular-cancer com
  • www.molecular-cancer .com
  • www.molecular-cancer. com
  • www.molecular-cancer,com
  • www.molecular-cancer,.com
  • www.molecular-cancer.,com
  • www.molecular-cancermcom
  • www.molecular-cancerm.com
  • www.molecular-cancer.mcom
  • www.molecular-cancer.ccom
  • www.molecular-cancer.om
  • www.molecular-cancer.ccom
  • www.molecular-cancer.xom
  • www.molecular-cancer.xcom
  • www.molecular-cancer.cxom
  • www.molecular-cancer.fom
  • www.molecular-cancer.fcom
  • www.molecular-cancer.cfom
  • www.molecular-cancer.vom
  • www.molecular-cancer.vcom
  • www.molecular-cancer.cvom
  • www.molecular-cancer.dom
  • www.molecular-cancer.dcom
  • www.molecular-cancer.cdom
  • www.molecular-cancerc.om
  • www.molecular-cancer.cm
  • www.molecular-cancer.coom
  • www.molecular-cancer.cpm
  • www.molecular-cancer.cpom
  • www.molecular-cancer.copm
  • www.molecular-cancer.cim
  • www.molecular-cancer.ciom
  • www.molecular-cancer.coim
  • www.molecular-cancer.ckm
  • www.molecular-cancer.ckom
  • www.molecular-cancer.cokm
  • www.molecular-cancer.clm
  • www.molecular-cancer.clom
  • www.molecular-cancer.colm
  • www.molecular-cancer.c0m
  • www.molecular-cancer.c0om
  • www.molecular-cancer.co0m
  • www.molecular-cancer.c:m
  • www.molecular-cancer.c:om
  • www.molecular-cancer.co:m
  • www.molecular-cancer.c9m
  • www.molecular-cancer.c9om
  • www.molecular-cancer.co9m
  • www.molecular-cancer.ocm
  • www.molecular-cancer.co
  • molecular-cancer.comm
  • www.molecular-cancer.con
  • www.molecular-cancer.conm
  • molecular-cancer.comn
  • www.molecular-cancer.col
  • www.molecular-cancer.colm
  • molecular-cancer.coml
  • www.molecular-cancer.co
  • www.molecular-cancer.co m
  • molecular-cancer.com
  • www.molecular-cancer.cok
  • www.molecular-cancer.cokm
  • molecular-cancer.comk
  • www.molecular-cancer.co,
  • www.molecular-cancer.co,m
  • molecular-cancer.com,
  • www.molecular-cancer.coj
  • www.molecular-cancer.cojm
  • molecular-cancer.comj
  • www.molecular-cancer.cmo
Show All Mistakes Hide All Mistakes
  • Copright © webzz.co.uk 2015-2024 all right reserved. 0.0449 map